Metacognitive Interpersonal Therapy Improves Adherence to Antiretroviral Therapies in a Man with a Severe Personality Disorder: A Case Report
Treatment adherence by patients with HIV ensures they gain the full benefit of antiretroviral medications and extend their lives. One problem which may contribute to poor adherence is deficits in metacognition or the capacity to make sense of mental states. In particular, persons who struggle to notice and think about their thoughts and feelings may be less able to direct their own recovery by taking advantage of effective treatments. This raises the possibility that treatments which lead to improved metacognitive function may enhance treatment adherence. We describe the case of a man in an advanced stage of AIDS with Kaposi’s sarcoma. The patient was treated with Metacognitive Interpersonal Therapy combined with psychoeducation about pharmacological treatment for HIV. Primary medical outcomes were suppression of viral load, increase of CD4 count and control of AIDS related conditions such as Kaposi’s sarcoma. The primary psychological outcome was reduction of personality disorders criteria. The patient was able to understand what led him to discontinue medication and then later regain full adherence. He achieved suppression of viral load and restore of CD4 count. As regard severity of personality disorder, he achieved reliable change. Interventions such as Metacognitive Interpersonal Therapy may assist patients with HIV to gain the metacognitive capacities to make sense of their medical and psychological challenges and adhere to antiretroviral therapies leading to enhanced levels of health. Future studies are needed to explore these findings in larger controlled studies.
KeywordsMetacognitive interpersonal therapy Therapy adherence HIV Personality disorders
All authors have made substantial contributions to conception and design of the study. All authors have been involved in drafting the manuscript and revising it critically for important intellectual content. All authors read and approved the final manuscript. S.S. has carried out patient psychotherapy. G.D. has carried out the supervision of the psychotherapy.
Compliance with Ethical Standards
Conflict of interests
The authors declare that they have no competing interests.
Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor of this journal.
- Dimaggio, G., Semerari, A., Carcione, A., Nicolò, G., & Procacci, M. (2007). Psychotherapy of personality disorders: Metacognition, states of mind and interpersonal cycles. London: Routledge.Google Scholar
- Dimaggio, G., Carcione, A., Nicolò, G., Lysaker, P. H., d’Angerio, S., Conti, M. L., Fiore, D., Pedone, R., Procacci, M., Popolo, R., & Semerari, A. (2013). Differences between axes depend on where you set the bar. Associations among symptoms, interpersonal relationship and alexithymia with number of personality disorder criteria. Journal of Personality Disorders, 27, 371–382. doi: 10.1521/pedi_2012_26_043.CrossRefPubMedGoogle Scholar
- Dimaggio, G., Valeri, S., Ottavi, P., Popolo, R., Salvatore, G., & Montano, A. (2014). Adopting metacognitive interpersonal therapy to treat narcissistic personality disorder with severe somatization. Journal of Contemporary Psychotherapy, 44, 85–95. doi: 10.1007/s10879-013-9254-8.CrossRefGoogle Scholar
- Dimaggio, G., Montano, A., Popolo, R., & Salvatore, G. (2015a). Metacognitive interpersonal therapy for personality disorders: A treatment manual. London: Routledge.Google Scholar
- Dimaggio, G., D’Urzo, M., Pasinetti, M., Salvatore, G., Lysaker, P. H., Catania, D., & Popolo, R. (2015b). Metacognitive interpersonal therapy for avoidant personality disorders and substance abuse. Journal of Clinical Psychology: In-Session, 71, 157–166. doi: 10.1002/jclp.22151.CrossRefPubMedGoogle Scholar
- Dimaggio, G., Conti, C., Lysaker, P. H., Popolo, R., Salvatore, G., & Sofia. S. A. (2016). Reauthoring one’s own life in the face of being HIV+. Promoting healthier narratives with Metacognitive Interpersonal Therapy. Journal of Constructivist Psychology, 1–16Google Scholar
- First, M. B., Gibbon, M., Spitzer, R. L, Williams, J. B. W., & Benjamin, L. S. (1997). Structured clinical interview for DSM-IV axis II personality disorders, (SCID-II). Washington, D.C.: American Psychiatric Press, Inc.Google Scholar
- Grierson, J., Bartos, M., De Visser, R., & McDonald, K. (2000). HIV futures II: the health and well being of people with HIV/AIDS in Australia. Monograph Series Number 17. The Australian Res. Centre in Sex, Health, and Society. Melbourne: La Trobe University.Google Scholar
- Holzemer, W. L., Corless, I. B., Nokes, K. M., Turner, J. G., Brown, M. A., Powell-Cope, G. M., Inouye, J., Henry, S. B., Nicholas, P. K., & Portillo, C. J. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STDs, 13(3), 185–197.CrossRefPubMedGoogle Scholar
- Langebeek, N., Gisolf, E. H., Reiss, P., Vervoort, S. C., Hafsteinsdóttir, T. B., Richter, C., Sprangers MAG, & Nieuwkerk, P. T. (2014). BMC Medicine, 12, 142. http://www.biomedcentral.com/1741-7015/12/142.
- Lysaker, P. H., Olesek, K., Buck, K., Leonhardt, B., Vohs, J., Dimaggio, G., Popolo, R., & Outcalt, J. (2014). Metacognitive mastery moderates the relationship of alexithymia with cluster C personality disorder traits in adults with substance use disorders. Addictive Behaviors, 39, 558–561. 10.1016/j.addbeh.2013.11.007.CrossRefPubMedGoogle Scholar
- Lysaker, P. H., Ringer, J. M., Buck, K. D., Grant, M., Olesek, K., Leudtke, B. L., Dimaggio, G., (2012). Metacognitive and social cognition deficits in patients with significant psychiatric and medical adversity a comparison between participants with schizophrenia and a sample of participants who are HIV-positive. The Journal of Nervous and Mental Disease, 200, 130–134.CrossRefPubMedGoogle Scholar
- McIntosh, R. C., Ironson, G., Antoni, M., Fletcher, M. A., & Schneiderman, N. (2016). Alexithymia, assertiveness and psychosocial functioning in HIV: Implications for medication adherence and disease severity. AIDS and Behavior, 20(2), 325–338. doi: 10.1007/s10461-015-1126-7.CrossRefPubMedGoogle Scholar
- Outcalt, J., Dimaggio, G., Popolo, R., Olesek, K. L., Buck, K., & Lysaker, P. H. (2016). Metacognition moderates the relationship of disturbances in attachment with severity of borderline personality disorder among persons in treatment for substance use disorders. Comprehensive Psychiatry, 64, 22–28.CrossRefPubMedGoogle Scholar
- Pratt R, Robinson N, Loveday HP, Pellowe CM, Franks PJ. (1998). Improvement in sexual drive and a falling viral load are associated with adherence to HAART therapy. Geneva: 12th World AIDS Conference.Google Scholar
- Safran, J. D., & Muran, J. C. (2000). Negotiating the therapeutic alliance. A relational treatment guide. New York, NY: Guilford.Google Scholar
- Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.Google Scholar